Sarepta Therapeutics, Inc.
EXON SKIPPING OLIGOMERS AND OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
Last updated:
Abstract:
Antisense oligomers, and antisense oligomer conjugates complementary to a selected target site in the human, dystrophin gene to induce exon 53 skipping are described.
Status:
Application
Type:
Utility
Filling date:
23 Apr 2019
Issue date:
8 Apr 2021